Clinical chemistry/immunoassay
Ended Awarded Last action
- Contract number
- N6264521F0169
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,022,460
Award facts
- Opportunity
-
- N6264521R0005 Solicitation number
- Contract value 100% obligated
- $2,022,460.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pensacola, FL 32512, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $240,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $420,615 | |
| Exercise an Option | $0 | |
| Funding Only Action | $420,615 | |
| Exercise an Option | $0 | |
| Funding Only Action | $420,615 | |
| Exercise an Option | $0 | |
| Funding Only Action | $100,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $280,410 | |
| Original award | $140,205 |
Show all 14
About this award
Abbott Laboratories Inc., through its Abbott Diagnostics Division, received a delivery order award from the Defense Health Agency on June 29, 2021, for clinical chemistry and immunoassay products and services. The contract, valued at $2.02 million with a completion date of March 31, 2026, will be performed in Pensacola, Florida, and is structured as a firm fixed-price delivery order under the General Services Administration's Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III). This award carries no small business set-aside designation and was made through full and open competition, consistent with Abbott's established federal contracting approach across the Defense Health Agency and Department of Veterans Affairs networks.
The delivery order falls within Abbott Diagnostics Division's broader federal portfolio of chemistry and immunoassay analyzer systems, reagents, and consumables that support clinical laboratory operations across military and veteran healthcare facilities. The Defense Health Agency utilizes such procurements to equip its medical treatment facilities with advanced diagnostic capabilities necessary for comprehensive patient testing. Abbott's extensive experience delivering similar systems—including Architect and Alinity analyzer platforms—across multiple federal healthcare agencies and its existing master contract vehicles with the Defense Health Agency positioned the company to fulfill this clinical laboratory support requirement for military medical operations.
Quick answers
Who was awarded contract N6264521F0169?
N6264521F0169 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on June 29, 2021.
How much is contract N6264521F0169 worth?
The government has obligated $2,022,460 on N6264521F0169.
Is contract N6264521F0169 an order under another contract?
Yes. N6264521F0169 is a delivery order under 36F79719D0024, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract N6264521F0169 competed?
The extent of competition for N6264521F0169 was full and open competition. The government received 7 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award